Robust Multi-Level LC-MS Workflows for Biosimilar Comparability Assessment

RECORD | Already taken place Th, 28.9.2023

Uses of the Xevo G3 QTof mass spectrometer in a case study of biosimilar mAb characterization at intact, subunit, and peptide level.

Go to the webinar

Waters Corporation: Robust Multi-Level LC-MS Workflows for Biosimilar Comparability Assessment

Join us for a live presentation highlighting the uses of the Xevo G3 QTof mass spectrometer in a case study of biosimilar mAb characterization at intact, subunit, and peptide level.

Presenter: Samantha Ippoliti (Principle Scientist, Discovery & Development- Biopharma, Waters Corporation)

Sam joined Waters (Milford, MA) in 2018 and has worked on a variety of applications for LC-MS based biopharmaceutical characterization, including peptide mapping analysis and method development, and intact/subunit analysis via reversed phase (RP) and ion exchange (IEX) -MS. Prior to joining Waters, she was part of the LC-MS characterization group supporting a biopharmaceutical developability assessment group at Novartis in Cambridge, MA. Sam acquired a BS-MS in Chemistry from Northeastern University in 2012.

Waters Corporation

Robust Multi-Level LC-MS Workflows for Biosimilar Comparability Assessment

Related content

Simultaneous Quantitation and Discovery analysis: Combining targeted and untargeted metabolomics on Orbitrap mass spectrometers

Analysis of Per- and Polyfluoroalkyl Substances (PFAS) in Wastewater

Non-Targeted Screening of Biosolids with the Xevo™ MRT Mass Spectrometer Reveals New Isoforms of PFAS

High Resolution Characterization of Lipid Nanoparticles Using the Xevo™ Charge Detection Mass Spectrometry (CDMS) Instrument - Single Particle Mass Analysis of Intact LNP-mRNA Formulations

Out-of-the-box workflow for PFAS quantitation using a fullscan high-resolution approach with the Orbitrap Exploris EFOX Mass Detector